PKM and cancer: Besides, Wnt signaling up-regulated LDHA,HK2 and PKM2 to enhance glycolysis in cancer cells and bone marrow mesenchymal stem cells (BM-MSCs) activated Wnt signaling in tumors via targeting SFRP1 due to the delivery of BM-MSC-derived exosome miR-1180 [29].